OVID - Latest News

Ovid Therapeutics Inc. (OVID), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $528.2M. Beta to the broader market is 0.23.

The article list below shows the most recent OVID headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent OVID Headlines

Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - Aug 13, 2026

Ovid Therapeutics (OVID) came out with a quarterly loss of $0. 08 per share versus the Zacks Consensus Estimate of a loss of $0.

Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

globenewswire.com - Aug 13, 2026

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.

Earnings Preview: Ovid Therapeutics (OVID) Q2 Earnings Expected to Decline

zacks.com - Aug 5, 2026

Ovid Therapeutics (OVID) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prep

Ally Bridge Group NY LLC Has $6.26 Million Position in Ovid Therapeutics $OVID

defenseworld.net - Jul 29, 2026

Ally Bridge Group NY LLC raised its stake in Ovid Therapeutics (NASDAQ: OVID) by 57. 9% during the undefined quarter, according to its most recent For

ADAR1 Capital Management LLC Acquires 259,113 Shares of Ovid Therapeutics $OVID

defenseworld.net - Jul 29, 2026

ADAR1 Capital Management LLC grew its holdings in Ovid Therapeutics (NASDAQ: OVID) by 6. 0% in the undefined quarter, according to its most recent dis

How News Affects OVID Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track OVID's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked OVID news questions

What is the latest OVID news headline?

The most recent OVID headline (Aug 13, 2026) is "Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the OVID news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What OVID news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual OVID options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.